Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06044285
Other study ID # HUM00226716
Secondary ID 1R01DA055027-01A
Status Recruiting
Phase N/A
First received
Last updated
Start date August 5, 2023
Est. completion date August 5, 2028

Study information

Verified date May 2024
Source University of Michigan
Contact Ashley Gearhardt, PhD
Phone 734-647-3920
Email agearhar@umich.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study experimentally investigates whether a reduction in ultra-processed (UP) food intake (1) causes aversive withdrawal symptoms in humans, (2) increases the motivational salience of UP food cues and, if so, (3) whether these factors undermine the ability to adhere to a low-UP diet. The following aims and hypotheses are tested: Aim 1: To investigate whether aversive physical, cognitive, and affective withdrawal symptoms emerge in response to reduced UP food intake compared to a high-UP diet, and whether this predicts failure to adhere to a low-UP diet. H1a: Reducing UP food intake will result in aversive physical, cognitive, and affective withdrawal symptoms, as indicated by 1) ecological momentary assessment (EMA) reports of aversive withdrawal symptoms, and 2) heart rate reactivity and subjective distress to an in-lab stressor. H1b: Aversive symptoms of UP food withdrawal will predict greater UP food intake and higher blood glucose levels when trying to adhere to a low UP diet. Aim 2: To investigate whether increased motivational salience of UP food cues emerges in response to reduced UP food intake, and whether this predicts failure to maintain a low-UP diet. H2a: Reducing UP food intake will result in increased motivational salience of UP food cues, as indicated by 1) EMA reports of UP food craving, 2) heart rate reactivity and subjective craving in a simulated fast-food restaurant, 3) heightened reinforcement value for UP food relative to other reinforcers, and 4) greater reward-related neural response to UP food cues. H2b: Increased motivational salience of UP food cues will predict greater UP food intake and higher blood glucose levels when trying to adhere to a low UP diet.


Description:

The study will include a combination of in-person, at-home, and virtual activities over the course of ~14 days (contingent on scheduling, this duration may vary and particularly between in-person visits #1 and #2). Participants complete three in-lab visits. Visit 1 and 2 will each followed by a week of remote data tasks (e.g., EMA, continuous glucose monitoring, physical activity and sleep tracking (Fitbit), and two 24-hour dietary recall interviews). During in-lab visit #1, participants will complete questionnaires, behavioral tasks, and interviews, and will have body composition measurements taken (height, weight, Inbody scan). Participants will complete the remote tasks for the following week while eating their typical diet (i.e., baseline period). During in-lab visit #2, participants will complete questionnaires, interviews, and body composition measurements (height, weight, Inbody scan). Participants are randomly assigned to one of three conditions--control (i.e., high UP), self-guided low UP, or meals provided low UP--and will follow instructions about how to eat consistent with their condition during week 2 of remote data collection (i.e., dietary intervention period). During in-lab visit #3, participants will complete questionnaires, behavioral tasks, body composition measurements (height, weight, InBody scan), and an fMRI scan. Participants are contacted 1- and 3-months later to complete a short follow-up survey and provide information about their current diet.


Recruitment information / eligibility

Status Recruiting
Enrollment 210
Est. completion date August 5, 2028
Est. primary completion date August 5, 2028
Accepts healthy volunteers No
Gender All
Age group 22 Years to 60 Years
Eligibility Inclusion Criteria: - 22 to 60 years of age - English-speaking - Must own an Android or iPhone Smartphone - Live within a 1-hour radius of the laboratory - endorsement of > 4 symptoms on the YFAS 2.0 completed during eligibility screener; at the time of consent, symptom count must remain above threshold for food addiction (this discrepany is based on a previously found tendency during pilot testing to overestimate food addiction symptoms at the time of screening) - Willing and able to follow specific dietary instructions provided by the study team - Willing and able to attend 3 in-person lab visits - Willing to complete 4 phone interviews about foods eaten in the past 24 hours - Willing to report daily intake of food - Like the taste of chocolate milkshake (for fMRI scan eligibility only). Exclusion Criteria: - participants with a self-reported BMI < 18.5 and > 40 - Current diagnosis of disorder that may impact study results or the ability to safely complete study tasks (hypothyroidism (uncontrolled by medication), diabetes, etc.) - History of food allergies - Unable to respond to brief questionnaires within 90-minutes during the day - Work night shifts or irregular shifts - Restrictive dietary requirements (e.g., vegan) or high levels of picky eating - Medications (e.g., insulin, antipsychotic medications) that may impact study results or safe completion of study tasks - Diagnosis of severe mental illness (e.g., schizophrenia, bipolar disorder) - Diagnosis of a restrictive eating disorder (e.g., Anorexia Nervosa, Bulimia Nervosa, purging disorder) within the last 5 years - Current diagnoses of disorders that can impact reward/metabolic functioning - 20+ pound weight fluctuation in the last 3-months - Prior weight loss surgery (e.g., bariatric surgery) - Currently pregnant, breastfeeding, trying to get pregnant, or within 6-months of having given birth - High levels or high-risk intake of alcohol or caffeine - Use of tobacco or nicotine in the past month - Use of THC cannabis within the past week - Unwillingness to abstain from THC cannabis, tobacco or nicotine during the main portion of the study (~22 days) - fMRI contraindications (e.g., claustrophobia, metal implants). - inability to complete a random report within 90 minutes

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Low UP (meals provided)
This study incorporates within- and between-subject comparisons. All participants complete a series of three in-lab visits with remote data collection: Visit 1 and the following week comprise the baseline assessment period. Visit 2 and the following week comprise the dietary intervention period. Food is provided by the study team for 7 days in accordance with a low UP diet. Visit 3 assesses post-dietary intervention outcomes. All participants will complete remote assessments at 1 month and 3 month follow-up.
Low UP (self-guided)
Visit 1 and the following week comprise the baseline assessment period. Visit 2 and the following week comprise the dietary intervention period. Participants are asked to eat a low UP diet according to study provided nutritional guidance. Visit 3 assesses post-dietary intervention outcomes. All participants will complete remote assessments at 1 month and 3 month follow-up.
Active Control
Visit 1 and the following week comprise the baseline assessment period. Visit 2 and the following week comprise the dietary intervention period. Participants are asked to eat as they normally do. Visit 3 assesses post-dietary intervention outcomes. All participants will complete remote assessments at 1 month and 3 month follow-up.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (6)

Lead Sponsor Collaborator
University of Michigan Brown University, National Institute on Drug Abuse (NIDA), Oregon Research Institute, Pennington Biomedical Research Center, University of Tasmania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Withdrawal Symptoms Withdrawal symptoms (e.g., anger, anxiety) will be assessed using ecological momentary assessment (EMA) on a scale from 1 (not at all) to 7 (extremely); higher scores indicate greater withdrawal symptoms. Assessed during dietary intervention period for 1 week
Primary Craving of ultra-processed (UP) foods Craving of UP foods will be assessed using EMA on a scale from 1 (not at all) to 7 (extremely); higher scores indicate greater craving of UP foods. Assessed during dietary intervention period for 1 week
Primary Low UP food intake Intake of low UP foods will be assessed using two 24 hour dietary recall interviews. Assessed during dietary intervention period for 1 week
Primary Self-Reported Low UP food intake Intake of low UP foods will be assessed using EMA reports of food intake. Responses will be coded into high and low UP food intake based on the NOVA classification. Assessed during dietary intervention period for 1 week
Secondary Reactivity to a stressor Stress reactivity will be assessed using an in-lab stress task that has participants listen to an audio recording of a current stressor in their life. Participants' heart rate in response to the audio recording, relative to a baseline measurement, will be used as an indicator of stress reactivity; an increase in heart rate will be indicative of greater stress reactivity. Assessed post-dietary intervention during in-lab Visit 3 (1 day)
Secondary Self-reported reactivity to a stressor Stress reactivity will be assessed using an in-lab stress task that has participants listen to an audio recording of a current stressor in their life. Participants' subjective ratings of reactivity will be assessed at baseline (prior to listening to the audio recording) and immediately after listening to the audio recording using the negative affect subscale from the Positive and Negative Affect Schedule (PANAS); each item is rated on a 1 (very slightly or not at all) to 5 (extremely) scale, with higher numbers indicating greater experienced affect; an increase in score, relative to baseline, will indicate greater stress reactivity. Assessed post-dietary intervention during in-lab Visit 3 (1 day)
Secondary Cue reactivity to a simulated fast food restaurant Participants will spend 5 minutes in a simulated fast food restaurant. Participants' heart rate in response to the simulated fast food restaurant, relative to a baseline measurement, will be used as an indicator of cue reactivity; increases in will be indicative of greater cue reactivity. Assessed post-dietary intervention during in-lab Visit 3 (1 day)
Secondary Self-reported cue reactivity to a simulated fast food restaurant Participants will spend 5 minutes in a simulated fast food restaurant. Participants' subjective craving will be assessed at baseline (prior to entering the restaurant) and while in the restaurant on a scale from 0 (no craving at all) to 100 (I have never craved food more), with greater numbers indicating higher craving; an increase in score, relative to baseline, will indicate greater cue reactivity. Assessed post-dietary intervention during in-lab Visit 3 (1 day)
Secondary Level of reinforcement value for ultra processed foods Participants will complete a computerized task that measures their willingness to work (i.e., reinforcement value) for a UP food gift card relative to a non-food gift card. Baseline assessed during in-lab Visit 1 (1 day); assessed again post-dietary intervention during in-lab Visit 3 (1 day)
Secondary Magnitude of neural reward-related response to tasting a milkshake Participants will complete an fMRI paradigm where they see a UP food cue (i.e., picture of a chocolate milkshake) that predict receipt of a UP food (i.e., a chocolate milkshake). The paradigm also includes a control cue (i.e., picture of a water glass) that predicts receipt of a tasteless solution (which contains the ionic components of saliva; 25 mM KCl and 2.5 mM NaHCO3 in distilled water). Participants' activation in neural regions associated with reward (e.g., mOFC, striatum) to the milkshake cue (relative to the water cue) will be used as a measure of increased reward-related response to UP food cues. Assessed post-dietary intervention during in-lab Visit 3 (1 day)
Secondary Blood Glucose Level Assessed using a continuous blood glucose monitor. Assessed during dietary intervention period for 1 week
See also
  Status Clinical Trial Phase
Completed NCT05046938 - Food Addiction and Motivational Interviewing in Nursing Students N/A
Recruiting NCT04192058 - Effect of Transcranial Direct-current Stimulation in Eating Behavior of Women With Fibromyalgia N/A
Recruiting NCT04126239 - Validation of a Food Addiction Screening Test
Completed NCT05649189 - Differences in Length of Telomere in Food Addicted vs Non Food Addicted Persons
Completed NCT04666831 - Adapted Motivational Interviewing and Cognitive Behavioural Therapy for Food Addiction N/A
Completed NCT04218097 - Food Addiction and Follow-up in Subjects With Obesity
Completed NCT04373343 - Food Addiction Clinical Treatment Program N/A
Completed NCT04311450 - Behavioral Weight Loss Treatment for Individuals With Food Addiction N/A
Completed NCT04105712 - The Biobehavioral Impact of Diet Quality on Affect and Craving N/A
Recruiting NCT06387719 - Precursors of Binge Eating Disorder in a Clinical Sample of Adolescents With Obesity
Completed NCT01175512 - Stress, Hormones, and Eating Early Phase 1
Recruiting NCT06030362 - Probiotic Intervention Study N/A
Recruiting NCT04626570 - Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid Obesity N/A
Recruiting NCT04692909 - Deep Transcranial Magnetic Stimulation (dTMS) of the Medial Prefrontal Cortex in Food Addiction and Obesity N/A
Recruiting NCT05437809 - Biobehavioral Reward Responses Associated With Consumption of Nutritionally Diverse Ultra-Processed Foods N/A